Login to Your Account



BIO 2012

Changes in EU Put Pricing, Reimbursement at Forefront

By Nuala Moran
Staff Writer

Monday, June 25, 2012
BOSTON – It's a long path from all the fascinating science discussed at BIO last week to getting a new drug into the hands of patients, and now in Europe, convulsions in the pricing and reimbursement environment are stretching the time from discovery to first revenues even further.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription